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Summary. Immunohistochemical studies of astro- 
cytoma tissue have predominately shown fibronectin 
(FN) positivity restricted to vessels and glial fibrillary 
acidic protein (GFAP) positivity in the parenchyma. 
Cultured glioma cell lines, however, express both FN 
and GFAP. We measured the DNA content of ex- 
plants of gliomas to determine if the ploidy of the 
FN-positive and GFAP-positive cells differed. Thirty- 
three explants from four high grade gliomas were 
cultured on slides. FN and GFAP markers were deter- 
mined by double immunofluorescence. The slides were 
stained by the Feulgen method, the explants relocated 
and the DNA content measured by microdensitometry 
using the CAS-100 instrument. Human leukocytes 
applied to the slides were used as a diploid standard. 
Eleven GFAP-positive explants were hyperdiploid 
and one hypodiploid. Five FN-positive explants were 
diploid, three hypodiploid and ten hyperdiploid. One 
FN-positive explant was biclonal with aneuploid sub- 
populations. Two hyperdiploid explants, each of 
which had monoclonal histogram patterns, expressed 
both FN and GFAP. We conclude that most FN- 
positive cells, in addition to GFAP-positive cells, from 
cultured gliomas represent neoplastic cells. These may 
be present in the tumor in low numbers or may result 
from marker switching in culture. 
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Cell culture is a powerful technique for investigating 
problems in tumor biology. However, it may yield 
results which are at odds with direct observations of 
histopathology. Cells cultured from human gliomas 
have been observed to express glial fibrillary acidic 
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protein (GFAP), a marker of astrocytes, as well as 
fibronectin (FN), a marker of mesenchymal cells (Big- 
ner et al. 1981; Jones et al. 1982; Paetau et al. 1980a; 
Ponten and Westermark 1978; McKeever et al. 1987; 
Nishiguchi et al. 1985; McKeever and Chronwall 
1984). Histological sections of gliomas stained for 
GFAP and FN almost always show GFAP in the 
tumor parenchyma and FN confined to the stroma 
(Chronwall et al. !983; Betlon et al. 1985; Jones et al. 
1982; Paetau et al. 1980b; Bigami et al. 1972; Deck et 
al. 1978; Deipech et al. 1978; Eng and Rubinstein 
1978). This raises the question of whether the FN- 
positive cells in culture are derived from the'malignant 
cells or the stroma. To answer this question, we'  have 
determined the DNA content and marker expression 
of explant cultures from four highgrade astrocytomas. 
Our results indicate that although some FN,posffive 
cells in culture may come from benign stromal cells, 
most are derived from tumor cells. 
Methods 
Explant cultures of human astrocytomas were obtained from 
surgically resected tissue as previously described (McKeever et 
al. 1981; McKeever et al. 1987). Necrotic areas, visible blood 
vessels and any encapsulating material were cut away under 
sterile conditions so that homogeneous viable tumor tissue re- 
mained. This tissue was minced into approximately 1-mm size 
pieces which were placed on Lab-Tek chamber slides (Lab-Tek, 
Miles Scientific, Naperville, IL, USA) in Ham's F10 medium 
with 10% fetal calf serum, from which remaining traces of FN 
were removed by absorption over a gelatine-agarose affinity 
column (Baldwin et al. 1985). The slides were placed in a well- 
humidified incubator with 10% CO2 at 37 ~ C. The culture medi- 
um was replaced weekly. Growth was checked periodically by 
phase microscopy and explants were harvested after 9 - 4 5  days 
of culture when sufficient growth was observed. 
When the explants were harvested, the medium was dis- 
carded and the slides fixed immediately in methanol for 15 min. 
The slides were allowed to air dry and human leukocytes were 
applied to one edge. The slides were washed in phosphate- 
buffered saline (PBS) for 15 s and flooded with 0.3% Saponin 
plus 1 mM EDTA in PBS (Sigma Chemical, St. Louis, MO, 
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USA) for 2 min. The slides were again washed with PBS, then 
100/al of rabbit anti-GFAP (Accurate Chemical and Scientifc 
Co., Westbury, NY, USA) were applied for 15 rain. After 
another PBS wash, 100 gl of rhodamine-conjugated goat anti- 
rabbit IgG (Cappel Division of Cooper Biomedical, Malvern, 
x 
PA, USA) at a dilution of 1 : 100 were applied to the slide for ,- 
o 
15 min. After another PBS wash, 100 Id of fluorescein- z 
conjugated goat anti-human fibronectin (Cooper Biomedical, < 
Malvern, PA) at a dilution of 1 : 50 were applied to the slide for o z
15 min. Slides were washed again in PBS, wet-mounted with 
distilled water, and examined for explant staining under a 
fluorescent microscope. Positivity was determined by 
comparison with positive and negative controls. Cell and tissue 
controls were the cultured cell lines U251 (GFAP +), U138 
(FN +), human fibroblasts (FN +) ;  and cryostat sections of 
brain tumor tissue (both GFAP + and FN +)  (Chronwall et al. 
1983). Negative staining controls were made by deletion of the 
primary antibody in the staining procedure and by absorption 
with human FN (Chronwall et al. 1983). The position of each 
explant was marked on the back of the slide with indelible ink 
so that it could be relocated. 
After immunofluorescent examination, slides were fixed in 
10% neutral buffered formalin for 5 min and stained by the 
Feulgen procedure as follows. Slides were placed in 5 M HC1 at 
room temperature for 60 min. Slides were transferred to stain 2 0  
solution (375 mg Azure A, 1.5 g K2S205 in 75 ml of 0.1 M HC1) 
for 2 h. Slides were rinsed three times for 5 rain in a solution of --I, 15 
0.2 g K . 2 S 2 O  5 in 300 ml of 0.05 M HC1. Slides were washed in '" o 
distilled water for 5 min, dehydrated in ethanol, cleared in xylene ~ 10 
and coverslipped. A standard slide with Rainbow Trout ~- 
erythrocytes (Cell Analysis Systems, Lombard, IL, USA) was 
included in each stain batch. 
5 
DNA analysis was performed with a Cell Analysis Systems z 
CAS-100 image analysis system. The trout erythrocytes and 
human leukocytes were used as DNA standards. Each explant 
was relocated and the integrated optical density of the Feulgen- 
stained nuclei was measured. One hundred cells or all cells in 
each explant were measured, whichever was less. Degenerating 
cells without a clear chromatin structure were not measured. 
The DNA index (DNAI) was calculated for the first modal peak 
of the histogram of nuclear DNA content, relative to the diploid 
value determined from the standards. The percentage of cells in 
the S plus G2/M phases of the cell cycle was calculated for each 
explant (except one explant which was biclonal). 
Gliomas were classified in accord with descriptions by 
Rubinstein (Rubinstein et al. 1972) and of Burger and Vogel 
(Burger and Vogel 1982). Gliomas were graded as described by 
Fulling and Nelson (Fulling and Nelson 1984). Correlation with 
the Kernohan grading system (Kernohan and Sayre 1952) was 
as described by Zulch (Zulch 1979). No attempt to sample a 
specific type of glioma was made other than to use cases which 
grew well enough as explants in culture to support the study. 
R e s u l t s  
Cases 1 and  4 were each  g l i o b l a s t o m a  mu l t i f o rme  
( K e r n o h a n  g rade  o f  IV). H i s to log ica l  sect ions o f  b o t h  
neop l a sms  c o n t a i n e d  subs tan t i a l  c o a g u l a t i o n  necros is  
and  min ima l  p ro l i f e r a t i on  o f  vascu la r  cells. Bo th  neo-  
p lasms  con ta ined  reg ions  o f  hyperce l lu la r i ty ,  mi toses  
and  t u m o r  g i an t  cells. The re  were m o r e  a b n o r m a l  
mi to t i c  f igures in case 4 than  in case 1. 
Cases  2 and  3 were anap la s t i c  a s t r o c y t o m a s  (Ker -  
n o h a n  g rade  o f  I I I ) .  Bo th  cases h a d  regions  o f  
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Fig. 1. Distribution of DNA index (DNAI) and marker ex- 
pression of cultured explants from the four gliomas in this study. 
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F i g .  2. Histogram of nuclear DNA content ofa fibronectin(FN)- 
positive explant with a biclonal pattern. The first and third peaks 
represent the Go/GI and G2/M populations of one clone with 
DNAI = 1.07. The second and fourth peaks are the Go/G1 and 
G2/M peaks of another clone with DNAI = 1.43 
m o d e r a t e  and  o the r  regions  o f  high cel lular  density.  
Gemis tocy te s  p r e d o m i n a t e d  in some regions  o f  case 2, 
bu t  were rare  in case 3. There  were a few mi toses  in 
b o t h  cases. Case 2 also con t a ined  rare  a b n o r m a l  
mi to t i c  spindles.  Nucle i  f r om b o t h  cases were 
m o d e r a t e l y  p l e o m o r p h i c  and  hype rc h roma t i c ,  s l ightly 
less p l e o m o r p h i c  in case 3. Both  h a d  m i n i m a l  p ro -  
l i fe ra t ion  o f  vascu la r  cells and  no  regions  o f  coagula -  
t ion  necrosis .  Mu l t i nuc l ea t ed  cells were re la t ively  
c o m m o n  in case 2 and  rare  in case 3. 
Th i r ty - th ree  exp lan t  cul tures  were o b t a i n e d  f rom 
the four  pat ients .  Twelve explan ts  were posi t ive  for  
G F A P ,  19 were posi t ive  for  F N  and  2 were s ta ined  by  
bo th  markers .  
The  D N A I  o f  the exp lan t s  is shown in Fig.  1. The  
D N A I  ranged  f rom 0.76 to / .51.  Al l  exp lan t s  except  
one were m o n o c l o n a l ,  as ev idenced  by  a single G0/G1 
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Fig. 3. Histogram of nuclear DNA content of a monoclonal 
explant, which was positive for both FN and glial fibrillary 
acidic protein. The major peak at 1.32 represents the Go/G1 
population. The second peak at 2.62, twice the DNA content of 
the base peak, represents the G2/M population 
peak with a variable S phase and G2/M peak. One 
FN-positive explant from patient 3 was biclonal 
(Fig. 2) with DNAIs of 1.07 and 1.43. Eleven GFAP- 
positive explants were hyperdiploid (DNAI > 1.05), 
and one was hypodiploid (DNAI = 0.91). Ten FN- 
positive explants were hyperdiploid (DNAI > 1.05), 
5 were diploid (0.95 < DNAI < 1.05), and 3 were 
hypodiploid (DNAI < 0.95). Two explants, both from 
patient 4, were positive for both markers. These had 
DNAIs of 1.32 and 1.26 with monoclonal histogram 
patterns (Fig. 3). Eight GFAP-positive and 14 FN- 
positive explants had cells with DNA contents above 
the G2/M peak. There was no significant relationship 
between DNAI and percentage of cells in the S plus 
G2/M phases of the cell cycle. There was no significant 
difference between the means of the DNAIs of the FN- 
positive and GFAP-positive explants (t-test p > 0.1). 
Discussion 
This study was undertaken to determine the relation- 
ship between marker expression, clonallity and DNA 
content in cultured cells obtained from human 
astrocytomas. All of the explants in this study, except 
one, had monoclonal patterns of DNA content. Evi- 
dence for monoclonallity was a single major peak (Go/ 
G1) with or without a minor peak at twice the DNA 
content (G2/M). Between these was a variable number 
of cells representing the S phase. This indicated that 
the cells of the explants growing in culture arose from 
a single original cell, or several cells having a common 
progenitor. One explant was biclonal, with two major 
Go/GI peaks, indicating that it arose from more than 
one stem cell in culture. 
The distribution of DNAI between the FN-posi- 
tive and GFAP-positive explants was similar. The lack 
of a statistically significant difference between the 
means of the FN- and GFAP-positive explants is evi- 
dence that they belong to the same population. There 
were aneuploid explants which expressed each marker. 
There was a tendency for the explants with DNAI 
close to one to be FN-positive. There were also 
hypodiploid explants which expressed each marker. 
Although the explants with DNAI of unity may have 
arisen from benign stromal elements of the tumor, it 
is likely that the aneuploid explants originated from 
neoplastic cells. In tissue sections of gliomas the 
GFAP expression is found in the glial regions, whereas 
the FN expression is largely confined to the vascu- 
lature (Bellon et al. 1985; Schiffer et al. 1984; Jones 
et al. 1982). Positive FN staining has been reported, 
however, within the interstitium (Jones et al. 1982) 
and the extracellular matrix (Bellon et al. 1985) of 
astrocytomas. Our experience is that, if FN staining 
is observed at all in the parenchyma, it is in very rare 
cells (Chronwall et al. 1983). Since the cells involved in 
the vascular proliferation of high grade astrocytomas 
have been shown to be diploid, regardless of the ploidy 
of the astrocytic component (Davenport and 
McKeever 1987), overgrowth by vascular cells could 
not account for the presence of FN-positive explants 
with aneuploidy. In addition, the high proportion of 
FN-expressing explants observed (21 out of 33) would 
be improbable if they arose from the relatively in- 
frequent FN-positive cells seen in tissue sections. 
There were two explants in this study which had 
monoclonal DNA patterns and expressed both 
markers. Both of these were aneuploid. It is unlikely 
then that the FN-positive cells in these cases were 
benign stromal cells. These two explants, therefore, 
represent neoplastic cells with the capacity to express 
both FN and GFAP. Both cells from primary culture 
of astrocytomas and established glial cell lines have 
been shown to express FN (McKeever et al. 1981, 
1987; McKeever and Chronwall 1984; Paetau et al. 
1980a; Jones et al. 1982; Ponten and Westermark 
1978; Bigner et al. 1981; Nishiguchi et al. 1985). In 
addition, there is evidence that glioma cells may switch 
from GFAP expression to FN expression early in 
culture (McKeever and Chronwal11984). Our findings 
could be explained by marker switching in culture or 
the presence of some FN-positive neoplastic cells in 
the original tumor. 
In this study there was diversity of nuclear DNA 
content among explants from the same tumor. Others 
have noted that there are multiple subpopulations 
within astrocytomas which differ in nuclear DNA 
content (Shapiro and Shapiro 1984; Hoshino et al. 
1982; Shapiro et al. 1981). However, previous studies 
have not correlated DNA content with initial ex- 
pression of well-defined protein markers in culture. 
These subpopulations also differ in phenotype such as 
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tumorigenicity, resistence to chemotherapeutic agents 
and, as in this study, expression of mesenchymal 
markers. This heterogeneity has therapeutic and 
prognostic implications which will require further 
study. 
It should be noted that the diploid explants in this 
study may in fact represent proliferations of neoplastic 
cells, because the measurement of nuclear DNA 
content probably underestimates the proportion of 
malignant cells. Cytogenetic studies have demonstrat- 
ed diploid and near diploid cells from tissue and pri- 
mary cell culture of gliomas which have numerical 
chromosome abnormalities, marker chromosomes 
and the presence of double minutes (Bigner et al. 
1985). The cytophotometric measurements of DNA 
content would not necessarily detect these abnor- 
malities, therefore explants within the diploid or near 
diploid range, whether GFAP- or FN-positive, may 
still have distinct cytogenetie abnormalities. 
We conclude from this study that the neoplastic 
cells derived from cultured human astrocytomas have 
the capability of expressing FN. These may be present 
in low numbers in the original tumor or result from 
marker switching in culture. 
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